Loading clinical trials...
Loading clinical trials...
This study will test if CP-690,550 is safe and effective in rheumatoid arthritis patients taking methotrexate who have an inadequate response to tumor necrosis factor inhibitor treatment.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Pfizer
NCT05961592 · Arthritis, Rheumatoid
NCT07017686 · Arthritis, Rheumatoid
NCT05038553 · Arthritis, Rheumatoid, Pain
NCT05790356 · Arthritis, Arthritis, Rheumatoid, and more
NCT05657847 · Arthritis, Rheumatoid, Arthritis, Psoriatic, and more
Pfizer Investigational Site
Birmingham, Alabama
Pfizer Investigational Site
Los Angeles, California
Pfizer Investigational Site
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions